Search

Your search keyword '"Robin, A"' showing total 4,125 results

Search Constraints

Start Over You searched for: Author "Robin, A" Remove constraint Author: "Robin, A" Journal blood Remove constraint Journal: blood
4,125 results on '"Robin, A"'

Search Results

1. Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study

2. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study

3. Decitabine in older patients with AML: quality of life results of the EORTC-GIMEMA-GMDS-SG randomized phase 3 trial

4. Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?

5. Type 1 VWD classification revisited: novel insights from combined analysis of the LoVIC and WiN studies

6. Daratumumab with lenalidomide as maintenance after transplant in newly diagnosed multiple myeloma: the AURIGA study

8. Phase 2 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

9. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation

11. Endothelial cell–leukemia interactions remodel drug responses, uncovering T-ALL vulnerabilities

12. Asciminib monotherapy as frontline treatment of chronic-phase chronic myeloid leukemia: results from the ASCEND study

13. Dietary methionine starvation impairs acute myeloid leukemia progression

14. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis

16. Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS

17. A phase 2 study of venetoclax plus R-CHOP as first-line treatment for patients with diffuse large B-cell lymphoma

18. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia

20. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

21. Plateletpheresis-associated lymphopenia in frequent platelet donors

22. Phase 3 Randomized Study of Daratumumab (DARA) + Bortezomib, Lenalidomide, and Dexamethasone (VRd) Versus Vrd Alone in Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Who Are Eligible for Autologous Stem Cell Transplantation (ASCT): Primary Results of the Perseus Trial

23. Risk-adapted treatment of acute promyelocytic leukemia: results from the International Consortium for Childhood APL

24. Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease

31. MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia

32. Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel

33. Daratumumab Plus Lenalidomide and Dexamethasone in Patients with Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Maia Age Subgroup Analysis

34. Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL

35. Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) Alone in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): Updated Analysis of the Phase 3 Maia Study

36. Preliminary Safety and Efficacy of Bgb-11417, a Novel Bcl-2 Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)

37. Daratumumab Plus Lenalidomide and Dexamethasone (D-Rd) Versus Lenalidomide and Dexamethasone (Rd) in Transplant-Ineligible Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM): Clinical Assessment of Key Subgroups of the Phase 3 Maia Study

38. Health-Related Quality of Life for Frail Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Treated with Daratumumab, Lenalidomide and Dexamethasone: Subgroup Analysis of MAIA Trial

39. Procoagulant platelet activation promotes venous thrombosis

40. Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

41. Cytoskeletal abnormalities and neutrophil dysfunction in WDR1 deficiency

43. The genetics of nodal marginal zone lymphoma

44. Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL

45. Hyperactive mTOR pathway promotes lymphoproliferation and abnormal differentiation in autoimmune lymphoproliferative syndrome

46. Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

48. Impact of TP53 on outcome of patients with myelofibrosis undergoing hematopoietic stem cell transplantation

49. Phase II clinical trial evaluating Abatacept in patients with steroid-refractory chronic graft versus host disease

50. Updated Results from an Open-Label Phase 1/2 Study of Favezelimab (anti-LAG-3) Plus Pembrolizumab in Relapsed or Refractory Classical Hodgkin Lymphoma

Catalog

Books, media, physical & digital resources